Drugs Made In America Acquisition II Corp. - Right (DMIIR) closed at $0.05 on November 6, 2026, up 0.4% from the previous close, on volume of 10,665 shares (30-day average 35,133).
Data as of November 6, 2026.
No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition II Corp. - Right trades on the stock market under the symbol DMIIR.
As of November 6, 2026, DMIIR stock price was flat at $0.05 with 10,665 million shares trading.
DMIIR has a beta of -0.31, meaning it tends to be less sensitive to market movements. DMIIR has a correlation of 0.00 to the broad based SPY ETF.
DMIIR has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
DMIIR support price is $.04 and resistance is $.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMIIR shares will trade within this expected range on the day.
